Director
Jean-Claude “JC” Kyrillos is a medical device and digital health executive. He is Chief Operating Officer at Tandem Diabetes Care (TNDM). Previously, he served as SVP and president for Diagnostics and Digital Solutions at Envista Dental (NYSE: NVST) and prior as SVP and general manager for Qualcomm Life until it was acquired by private equity investor Francisco Partners. Mr. Kyrillos has over 30 years of diversified business experience, including over 20 years of executive leadership in the medical device industry serving acute care, homecare, and diagnostics. Prior to Qualcomm Life, he was the worldwide vice president and general manager of BD’s (Becton Dickinson) global Infusion Solutions business (previously CareFusion). In this role, he led BD’s Alaris infusion pump systems, including embedded and enterprise software with over $1 billion in annual revenues and ~5,000 global employees. Before BD/CareFusion, Mr. Kyrillos was president, ResMed Ventures and Initiatives and previously co-leader for ResMed, Americas, focused on sleep-disordered breathing, including obstructive sleep apnea. Earlier in his career, he held several positions at Honeywell International, including finance leader for a $500 mil in annual revenues electronic materials business where he was based for three years in Hong Kong. Mr. Kyrillos previously served on the Board of Directors for the Sharp Healthcare Foundation and serves as a student mentor for children who are the first generation from their family to attend college via A Bridge for Kids and the Georgetown Scholarship Program. He earned an MBA from Harvard Business School and a BA with Honors in History from Colgate University. Mr. Kyrillos joined the SDBB Board in 2016.
